The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches Proprietary Jack Haze Strain
- Supreme Cannabis subsidiary 7ACRES recently released its first sativa-dominant strain, with rare sensory characteristics differentiating the high-end flower offering
- Supreme Cannabis is positioned to develop value-add new cannabis products with its acquisition of Truverra
- The company’s collaboration with PAX Labs Inc. creates inroads into the lucrative Canadian vaporizer segment
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a diversified portfolio of cannabis brands that deliver positive experiences, continues to expand through several brand offerings designated for its discerning customer base. Through its various brands, SPRWF continues to synthesize its consumer-driven approach with a strong foundation of business fundamentals to realize promising revenue goals.
Recently, SPRWF announced the initial market entry of Jack Haze, a proprietary strain from its 7ACRES subsidiary. The unique 7ACRES Jack Haze strain is the first of a series designed to differentiate the high-end flower offering of 7ACRES from that of its competitors. That superior quality, the company says, will enable it to maintain premium pricing across Canada. Jack Haze is the company’s first sativa-dominant strain, offering rare sensory characteristics and a crisp and zesty evergreen flavor with visual appeal. The Jack Haze strain will be available in September in select Canadian provinces supplied by 7ACRES (http://cnw.fm/ISk86).
“This cultivar’s expression possesses a unique haze profile with a classic, sweet sativa smell and strong visual appeal,” Chief Advocacy Officer and Founder John Fowler stated in a news release. “As we develop and introduce unique strains, we further differentiate 7ACRES’ high end flower offering and continue to achieve premium pricing across Canada.”
As the company enhances and expands its flower offering under its 7ACRES brand, it is also taking steps to prepare for ‘Cannabis 2.0’ products in Canada. SPRWF recently acquired Toronto-based and privately held Truverra. This move intensifies Supreme Cannabis’ focus on expanding its cannabis presence in Canada (http://cnw.fm/THE1e).
Through the acquisition of Truverra, Supreme Cannabis gained a 5,000-square-foot Health Canada licensed facility in Scarborough, Ontario. Truverra’s wholly owned subsidiary, Canadian Clinical Cannabinoids Inc. operates this strategically located and licensed facility. From this operating asset, Supreme Cannabis is preparing to produce high-quality cannabis extracts, including concentrates and vaping liquids.
“The recent introduction of Health Canada’s amended cannabis regulations creates a distinct opportunity for Supreme Cannabis to establish a leading position in the cannabis extracts markets,” SPRWF CEO Navdeep Dhaliwal stated in a news release. “With the acquisition of Truverra, we secure a Toronto-based facility equipped to extract our high-quality inputs for concentrates and vaping liquids in the near-term.”
Deepening its Canadian market presence, Supreme Cannabis has also partnered with PAX Labs Inc. (http://cnw.fm/QG8j3), a market leader with over 1.5 million devices sold worldwide and a “reputation as the best pen-and-pod system in the U.S.” This move allowed Supreme Cannabis to become a foundational brand partner and supplier for the PAX Era in Canada. Supreme Cannabis’ subsidiary, 7ACRES, was one of only four licensed producers chosen to be an initial partner in creating cannabis oil pods for the PAX Era.
Analysts from CFN Media Group (http://cnw.fm/3kIIa) noted in a recent report that “nothing speaks more clearly to the ability to scale than Supreme this month providing revenue guidance for the next year in the range of $150 million to $180 million.” The article adds that “the robust growth is owed to management’s ability to make prescient moves to stay in front of regulation changes in addition to operational excellence.”
The Supreme Cannabis portfolio includes 7ACRES, its wholly owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a cultivation IP and plant genetics firm; Medigrow Lesotho, a cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Supreme Cannabis subsidiary 7ACRES recently released its first sativa-dominant strain, with rare sensory characteristics differentiating the high-end flower offering
- Supreme Cannabis is positioned to develop value-add new cannabis products with its acquisition of Truverra
- The company’s collaboration with PAX Labs Inc. creates inroads into the lucrative Canadian vaporizer segment
The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a diversified portfolio of cannabis brands that deliver positive experiences, continues to expand through several brand offerings designated for its discerning customer base. Through its various brands, SPRWF continues to synthesize its consumer-driven approach with a strong foundation of business fundamentals to realize promising revenue goals.
Recently, SPRWF announced the initial market entry of Jack Haze, a proprietary strain from its 7ACRES subsidiary. The unique 7ACRES Jack Haze strain is the first of a series designed to differentiate the high-end flower offering of 7ACRES from that of its competitors. That superior quality, the company says, will enable it to maintain premium pricing across Canada. Jack Haze is the company’s first sativa-dominant strain, offering rare sensory characteristics and a crisp and zesty evergreen flavor with visual appeal. The Jack Haze strain will be available in September in select Canadian provinces supplied by 7ACRES (http://cnw.fm/ISk86).
“This cultivar’s expression possesses a unique haze profile with a classic, sweet sativa smell and strong visual appeal,” Chief Advocacy Officer and Founder John Fowler stated in a news release. “As we develop and introduce unique strains, we further differentiate 7ACRES’ high end flower offering and continue to achieve premium pricing across Canada.”
As the company enhances and expands its flower offering under its 7ACRES brand, it is also taking steps to prepare for ‘Cannabis 2.0’ products in Canada. SPRWF recently acquired Toronto-based and privately held Truverra. This move intensifies Supreme Cannabis’ focus on expanding its cannabis presence in Canada (http://cnw.fm/THE1e).
Through the acquisition of Truverra, Supreme Cannabis gained a 5,000-square-foot Health Canada licensed facility in Scarborough, Ontario. Truverra’s wholly owned subsidiary, Canadian Clinical Cannabinoids Inc. operates this strategically located and licensed facility. From this operating asset, Supreme Cannabis is preparing to produce high-quality cannabis extracts, including concentrates and vaping liquids.
“The recent introduction of Health Canada’s amended cannabis regulations creates a distinct opportunity for Supreme Cannabis to establish a leading position in the cannabis extracts markets,” SPRWF CEO Navdeep Dhaliwal stated in a news release. “With the acquisition of Truverra, we secure a Toronto-based facility equipped to extract our high-quality inputs for concentrates and vaping liquids in the near-term.”
Deepening its Canadian market presence, Supreme Cannabis has also partnered with PAX Labs Inc. (http://cnw.fm/QG8j3), a market leader with over 1.5 million devices sold worldwide and a “reputation as the best pen-and-pod system in the U.S.” This move allowed Supreme Cannabis to become a foundational brand partner and supplier for the PAX Era in Canada. Supreme Cannabis’ subsidiary, 7ACRES, was one of only four licensed producers chosen to be an initial partner in creating cannabis oil pods for the PAX Era.
Analysts from CFN Media Group (http://cnw.fm/3kIIa) noted in a recent report that “nothing speaks more clearly to the ability to scale than Supreme this month providing revenue guidance for the next year in the range of $150 million to $180 million.” The article adds that “the robust growth is owed to management’s ability to make prescient moves to stay in front of regulation changes in addition to operational excellence.”
The Supreme Cannabis portfolio includes 7ACRES, its wholly owned subsidiary and multi-award-winning brand; Blissco Cannabis Corp., a wellness cannabis brand and a multi-licensed processor and distributor based in British Columbia; Truverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a cultivation IP and plant genetics firm; Medigrow Lesotho, a cannabis oil producer located in southern Africa; Supreme Heights, an investment platform focused on CBD brands in the UK and Europe; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.
For more information, visit the company’s website at www.Supreme.ca
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
